Top compounds associated with response to LCORL

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.1	0.004
mRNA	AKT inhibitor VIII	GDSC1000	pan-cancer	AAC	-0.1	0.004
mRNA	XL765	CTRPv2	pan-cancer	AAC	0.11	0.004
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.092	0.004
mRNA	BRD-M00053801	CTRPv2	pan-cancer	AAC	0.14	0.004
mRNA	Vandetanib	CCLE	pan-cancer	AAC	-0.14	0.005
mRNA	pac-1	CTRPv2	pan-cancer	AAC	0.11	0.005
mRNA	Dasatinib	CTRPv2	pan-cancer	AAC	-0.1	0.005
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.1	0.005
mRNA	BRD-K13999467	CTRPv2	pan-cancer	AAC	0.1	0.005

Download CSV